Cargando…
A study of motivations and expectations of patients seen in phase 1 oncology clinics
BACKGROUND: To better inform clinical practice, this study was aimed at capturing patients' motivations for enrolling in phase 1 trials and at quantifying their expectations of the benefits, risks, and commitment associated with clinical trials and the impact of the initial consultation on thei...
Autores principales: | Dolly, Saoirse O., Kalaitzaki, Eleftheria, Puglisi, Martina, Stimpson, Sarah, Hanwell, Janet, Fandos, Sonia Serrano, Stapleton, Sarah, Ansari, Thushara, Peckitt, Clare, Kaye, Stan, Lopez, Juanita, Yap, Timothy A., van der Graaf, Winette, de Bono, Johann, Banerji, Udai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111585/ https://www.ncbi.nlm.nih.gov/pubmed/27716902 http://dx.doi.org/10.1002/cncr.30235 |
Ejemplares similares
-
Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
por: Pal, Abhijit, et al.
Publicado: (2021) -
Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials
por: Ang, Joo Ern, et al.
Publicado: (2012) -
A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic
por: Tiu, Crescens, et al.
Publicado: (2020) -
RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses
por: Dolly, Saoirse O, et al.
Publicado: (2017) -
High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy
por: Perez-Lopez, Raquel, et al.
Publicado: (2017)